Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +3 vs. Q2 2023
- Shares held
- 15.1M
- −32.7K (−0.2%) vs. Q2 2023
- Total value
- $144.3M
- −$51.7M (−26.4%) vs. Q2 2023
- New holders
- 4
- 15 more added
- Sold out
- 1
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 12 | $115 | 0.00% | +12 | New |
| Toronto Dominion Bank | 41 | $392 | 0.00% | +41 | New |
| UBS Group AG | 102 | $975 | 0.00% | −9,678−99.0% | Reduced |
| Qube Research & Technologies Ltd | 138 | $1.32K | 0.00% | +138 | New |
| Citigroup Inc | 230 | $2.20K | 0.00% | −2,560−91.8% | Reduced |
| FMR LLC | 288 | $2.75K | 0.00% | −134−31.8% | Reduced |
| Ameritas Investment Partners, Inc. | 695 | $6.64K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 800 | $7.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 839 | $8.02K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,255 | $12.0K | 0.00% | +523+71.4% | Added |
| Amalgamated Bank | 1,344 | $13.0K | 0.00% | +563+72.1% | Added |
| Allspring Global Investments Holdings, LLC | 1,564 | $15.0K | 0.00% | +1,564 | New |
| Royal Bank of Canada | 1,561 | $15.0K | 0.00% | +654+72.1% | Added |
| California State Teachers Retirement System | 1,918 | $18.3K | 0.00% | −973−33.7% | Reduced |
| Wells Fargo & Company | 2,161 | $20.7K | 0.00% | −1,144−34.6% | Reduced |
| New York State Common Retirement Fund | 2,297 | $22.0K | 0.00% | +22+1.0% | Added |
| American International Group, Inc. | 4,338 | $41.5K | 0.00% | +155+3.7% | Added |
| Morgan Stanley | 4,943 | $47.3K | 0.00% | −3,562−41.9% | Reduced |
| Bank of America Corp | 9,332 | $89.2K | 0.00% | +1,708+22.4% | Added |
| Rhumbline Advisers | 9,477 | $90.6K | 0.00% | +491+5.5% | Added |
| Exchange Traded Concepts, LLC | 9,919 | $94.8K | 0.00% | −1,790−15.3% | Reduced |
| AAFCPAs Wealth Management, LLC | 10,678 | $102.1K | 0.07% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 11,821 | $113.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 14,100 | $134.8K | 0.00% | −163−1.1% | Reduced |
| Bank of New York Mellon Corp | 24,795 | $237.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 26,572 | $254.0K | 0.00% | +19,645+283.6% | Added |
| D. E. Shaw & Co., Inc. | 46,750 | $446.9K | 0.00% | −160−0.3% | Reduced |
| Charles Schwab Investment Management Inc | 67,661 | $646.8K | 0.00% | +6,703+11.0% | Added |
| Northern Trust Corp | 72,722 | $695.2K | 0.00% | +4,044+5.9% | Added |
| DAFNA Capital Management LLC | 76,852 | $734.7K | 0.23% | 00.0% | Unchanged |
| UBS Oconnor LLC | 105,000 | $1.00M | 0.02% | +5,000+5.0% | Added |
| State Street Corp | 133,276 | $1.27M | 0.00% | +7,300+5.8% | Added |
| Geode Capital Management, LLC | 189,559 | $1.81M | 0.00% | +11,106+6.2% | Added |
| Federated Hermes, Inc. | 226,375 | $2.16M | 0.01% | −78,036−25.6% | Reduced |
| NEA Management Company, LLC | 430,252 | $4.11M | 0.32% | −51,425−10.7% | Reduced |
| Vanguard Group Inc | 468,407 | $4.48M | 0.00% | +65,132+16.2% | Added |
| BlackRock Inc. | 528,760 | $5.05M | 0.00% | −4,595−0.9% | Reduced |
| Marshall Wace, LLP | 597,469 | $5.71M | 0.01% | 00.0% | Unchanged |
| Wellington Management Group LLP | 888,130 | $8.49M | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,650,457 | $15.8M | 0.02% | +8110.0% | Added |
| Sands Capital Ventures, LLC | 1,652,605 | $15.8M | 4.67% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $28.8M | 0.97% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,810,508 | $46.0M | 0.91% | 00.0% | Unchanged |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,062−100.0% | Sold out |